Clinical Trial Update: A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia [Phase 4]

View source ↗

Summary

A Phase 4 study comparing vardenafil to placebo in men with erectile dysfunction and dyslipidemia has completed. Sponsor: GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Erectile Dysfunction

Drugs mentioned

• Vardenafil (vardenafil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Erectile Dysfunction | Phase 4 | Status: COMPLETED